Cidara Therapeutics, Inc.
Institutional Ownership & Holdings Analysis
About
cidara-therapeutics is a publicly traded company tracked by institutional investors. This page displays information about the institutional ownership of the company's shares, showing which investment funds and asset managers hold positions in the company.
Top Institutional Holders
# | Institution | Value |
---|---|---|
1 | RA CAPITAL MANAGEMENT, L.P.(2025-03-31) | $23.5M |
2 | VR Adviser, LLC(2025-03-31) | $22.6M |
3 | TCG Crossover Management, LLC(2025-03-31) | $21.7M |
4 | ADAGE CAPITAL PARTNERS GP, L.L.C.(2025-03-31) | $21.3M |
5 | BVF INC/IL(2025-03-31) | $19.9M |
6 | Bain Capital Life Sciences Investors, LLC(2025-03-31) | $15.1M |
7 | Vivo Capital, LLC(2025-03-31) | $14.7M |
8 | VANGUARD GROUP INC(2025-03-31) | $11.0M |
9 | Vestal Point Capital, LP(2025-03-31) | $10.9M |
10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP(2025-03-31) | $7.4M |
11 | CITADEL ADVISORS LLC(2025-03-31) | $6.2M |
12 | Ikarian Capital, LLC(2025-03-31) | $5.4M |
13 | ACUTA CAPITAL PARTNERS, LLC(2025-03-31) | $2.7M |
14 | Aberdeen Group plc(2025-03-31) | $2.6M |
15 | Point72 Asset Management, L.P.(2025-03-31) | $2.5M |
16 | Checkpoint Capital L.P.(2025-03-31) | $2.2M |
17 | RENAISSANCE TECHNOLOGIES LLC(2025-03-31) | $2.0M |
18 | BOOTHBAY FUND MANAGEMENT, LLC(2025-03-31) | $1.7M |
19 | UBS Group AG(2025-03-31) | $1.4M |
20 | MILLENNIUM MANAGEMENT LLC(2025-03-31) | $1.4M |
As of 2025-03-31
Value:$23.5M
As of 2025-03-31
Value:$22.6M
As of 2025-03-31
Value:$21.7M
As of 2025-03-31
Value:$21.3M
As of 2025-03-31
Value:$19.9M
As of 2025-03-31
Value:$15.1M
As of 2025-03-31
Value:$14.7M
As of 2025-03-31
Value:$11.0M
As of 2025-03-31
Value:$10.9M
As of 2025-03-31
Value:$7.4M
As of 2025-03-31
Value:$6.2M
As of 2025-03-31
Value:$5.4M
As of 2025-03-31
Value:$2.7M
As of 2025-03-31
Value:$2.6M
As of 2025-03-31
Value:$2.5M
As of 2025-03-31
Value:$2.2M
As of 2025-03-31
Value:$2.0M
As of 2025-03-31
Value:$1.7M
#19UBS Group AG
As of 2025-03-31
Value:$1.4M
As of 2025-03-31
Value:$1.4M
Total Institutional Holders:49
Top 10 Holders Own:81.2%